Merve Türkkol

Merve Türkkol

Auto-generated profile, based on publicly available information

Merve Türkkol

Hamidiye Faculty of Medicine, Department of Neurology, Sancaktepe Prof. Dr. Ilhan Varank SUAM, University of Health Sciences, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2025 in BMC Neurology
Verified
Journal Article
Open access
PDF file
OTOzlem Totuk
Ozlem Totuk
MTMerve Türkkol
Merve Türkkol
FYFeyzullah Yadi
Feyzullah Yadi
HGHasan Can Güdek
Hasan Can Güdek
GEGüldeniz Çetin Erci
Güldeniz Çetin Erci
SDSerkan Demir
Serkan Demir
Sexual dysfunction (SD) is a prevalent but underreported symptom in people with multiple sclerosis (pwMS), significantly affecting quality of life (QoL). Despite its clinical relevance, SD is often overlooked during routine care. This study aimed to determine the prevalence of SD, identify associated risk factors, assess its impact on depression and QoL, and explore help-seeking behaviors among pwMS. A cross-sectional study was conducted with 504 pwMS followed at a tertiary MS clinic between November 2023 and May 2024. Data on demographics, disease characteristics, and medications were collected. The Arizona Sexual Experiences Scale (ASEX) was used to assess SD, the Beck Depression Inventory (BDI) for depression, and the Short Form-12 (SF-12) for QoL. EDSS scores were used to evaluate disability. Statistical analyses included t-tests, ANOVA, chi-square, correlation analyses, and univariate and multivariate logistic regression, with significance set at p < 0.05. SD was identified in 69.0% of patients (73.9% of women, 57.6% of men). SD was significantly associated with female gender (p = 0.001), older age (p = 0.006), higher EDSS scores (p = 0.046), and increased depression levels (r = 0.38). SF-12 scores were significantly lower among those with SD (p < 0.001). In multivariate analysis, female gender (aOR = 2.01, p = 0.002) and higher BDI scores (aOR = 1.09, p < 0.001) remained independently associated with SD, while age and EDSS did not. No significant associations were found between SD and MS type, disease duration, or type of disease-modifying therapy. Only 9.8% of patients with SD sought medical help, while 83.1% did not seek support. SD is highly prevalent among pwMS and is closely linked to age, disability, depression, and reduced QoL. Depression emerged as a strong independent predictor. Despite this burden, most patients do not seek help. Multidisciplinary approaches and routine screening are essential to address SD in clinical settings.

21 July 2025 in Brain and Behavior
Verified
Journal Article
Open access
OTOzlem Totuk
Ozlem Totuk
MTMerve Turkkol
Merve Turkkol
EUEbru Hatun Uludaşdemir
Ebru Hatun Uludaşdemir
HGHasan Can Güdek
Hasan Can Güdek
GEGuldeniz Cetin Erci
Guldeniz Cetin Erci
SDSerkan Demir
Serkan Demir
Background and purpose: Social cognition (SC) is increasingly recognized as a key cognitive domain affected in multiple sclerosis (MS), yet its sub‐domains and clinical correlates remain underexplored. This study aimed to assess different SC sub‐domains and identify their cognitive, emotional, and demographic predictors in people with MS (pwMS). Methods: This cross‐sectional study included 93 pwMS and 34 HCs. Assessments included the Reading the Mind in the Eyes Test (RMET) for emotion recognition, the Trail Making Test (TMT) for executive function, the Tromso Social Intelligence Scale (TSIS) for nonverbal understanding, the Implied Meaning Test (IMT) for implicit understanding, the Social‐Emotional Competence Scale for adaptability, the Barratt Impulsiveness Scale for impulsivity, the Stroop Test for inhibition, the Beck Depression Inventory (BDI) for depression, the Montreal Cognitive Assessment (MoCA) for cognition, and the Short Form‐12 (SF‐12) for quality of life (QoL). Multiple regression analyses were conducted to identify independent predictors of SC performance. Results: PwMS, particularly those with progressive MS, exhibited significantly lower SC performance across all sub‐domains compared to HCs. Regression analyses revealed that lower MoCA scores, higher BDI scores, and lower educational attainment were significant predictors of impaired SC, while disease duration and gender were not. Notably, SC deficits were also observed in cognitively preserved individuals, suggesting the relative independence of SC impairments. Conclusion: SC impairment is a distinct and clinically relevant feature of MS, associated with both cognitive and emotional factors. Routine SC screening may enhance patient care by informing personalized interventions. Future research should include larger cohorts, longitudinal designs, and practical SC assessment tools for clinical use.

30 April 2024 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
OTOzlem Totuk
Ozlem Totuk
MTMerve Türkkol
Merve Türkkol
Delusional misidentification syndrome is characterized by individuals perceiving familiar people, places, and objects as different entities, often associated with delusional disorders. These disorders are typically linked to abnormalities in cognitive processes, resulting in incongruent and unalterable beliefs. The loss of familiarity is believed to be the consequence leading to the emergence of these disorders. While commonly associated with psychiatric illnesses, they are also frequently observed in conjunction with neurodegenerative diseases. Diagnosis is primarily established through clinical evaluation. However, cases of these syndromes pose a significant burden on caregivers. Therefore, it is crucial not to overlook the possibility of dementia in these syndromes. This consideration is vital for providing appropriate support and treatment to patients and their families. This case report aimed to provide a detailed examination of this topic by presenting five cases.

29 April 2025 in Maltepe Tıp Dergisi
Verified
Journal Article
Closed access
OTOzlem Totuk
Ozlem Totuk
MTMerve Türkkol
Merve Türkkol
ESEsra Nur Sancar
Esra Nur Sancar
MÜMeltem Baykan Ünsal
Meltem Baykan Ünsal
SSSevki Sahin
Sevki Sahin
Amaç: Demans hastalarında morbidite ve mortalitenin önemli nedenlerinden biri olan “düşme riski” üzerine beslenme yetersizliği ve çoklu ilaç kullanımının etkilerini değerlendirilmesi amaçlanmıştır. Materyal ve Metodlar: Bu kesitsel çalışma, demans polikliniğinde en az bir yıldır takip edilen erken evre demans hastalarını kapsamaktadır. Polifarmasi ölçütü olarak beşten fazla ilaç kullanımı seçilmiş ve ilaç tipleri alt gruplara ayrılmıştır. Hastalara Morse Düşme Ölçeği ve Mini Nutrisyonel Değerlendirme Ölçeği uygulandı. Bulgular: Çalışmaya toplamda 240 demans hastası (150 kadın): Alzheimer Demans, Frontotemporal Demans, Lewy Cisimcikli Demans ve Vasküler Demans randomize olarak dahil edilmiştir. Malnütrisyon ve polifarmasinin düşme riskini artırdığı gözlemlenmiş, en yüksek risk psikotrop ilaç grubunda bulunmuştur. Tek antipsikotik kullanımının antipsikotik ve antidepresan birlikteliğine göre düşme riskini daha çok arttırdığı gözlenmiş olup, bu durum yüksek antipsikotik ilaç dozları ile ilişkilendirilmiştir. Sonuç: Malnütrisyon, özellikle psikopolifarmasi ile bir araya geldiğinde düşme ve buna bağlı morbidite ve mortaliteyi ciddi oranda arttırmaktadır. Sık aralıklarla malnütrisyon takibinin yapılması ve olabildiğince az miktarda, kısa sürelerde ve kısıtlı endikasyonlarda psikotropik ilaçların kullanılması gereklidir. Anahtar Kelimeler: Beslenme, demans, düşme, kognitif bozukluk, , polifarmasi

30 December 2025 in Archives of Clinical Neuropsychology
Verified
Journal Article
Closed access
OTOzlem Totuk
Ozlem Totuk
MTMerve Turkkol
Merve Turkkol
HGHasan Can Gudek
Hasan Can Gudek
IDIpek Gungor Dogan
Ipek Gungor Dogan
DTDamla Cetinkaya Tezer
Damla Cetinkaya Tezer
SDSerkan Demir
Serkan Demir
Objective: This study examined metacognitive belief profiles in individuals with multiple sclerosis (MS) and their associations with cognitive, emotional, and functional outcomes. Specifically, we compared relapsing–remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS) to determine whether distinct metacognitive patterns characterize different disease phenotypes. Method: A total of 504 participants (75.6% RRMS, 9.9% SPMS, 14.5% PPMS) were recruited from a neurology clinic. Participants completed the Metacognitions Questionnaire-30 (MCQ-30), Montreal Cognitive Assessment (MoCA), Beck Depression Inventory (BDI), Modified Fatigue Impact Scale (MFIS), Expanded Disability Status Scale (EDSS), Short Form-12 (SF-12), and Occupational Self-Assessment (OSA). Group differences were examined using ANOVA, correlations via Pearson coefficients, and hierarchical and ordinal regression models. Results: Progressive phenotypes, particularly PPMS, showed significantly higher maladaptive metacognitive beliefs than RRMS. RRMS individuals exhibited greater cognitive self-consciousness and need for control, whereas PPMS was associated with lower cognitive confidence and stronger negative beliefs about uncontrollability. No subtype differences emerged in positive beliefs. Maladaptive metacognition correlated with lower cognitive performance, greater fatigue, depressive symptoms, reduced quality of life, and lower self-efficacy. In regression models, depression was the strongest negative predictor of self-efficacy, while cognitive self-consciousness was a positive predictor. Clinical and psychological variables together explained 60% of the variance in self-efficacy. Metacognitive beliefs and fatigue also predicted higher neurological disability (EDSS). Conclusions: Metacognitive belief patterns differ across MS phenotypes and significantly impact both functional and neurological outcomes. These findings support incorporating metacognitive assessment into routine MS care and underscore the need for tailored psychological interventions addressing cognitive-emotional regulation.